mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys-Reference-Cited by-同舟云学术

mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys

Published:2008-07 Issue:7 Volume:29 Page:1040-1051
ISSN:0197-4580
Container-title:Neurobiology of Aging
language:en
Short-container-title:Neurobiology of Aging

Author:

Samadi Pershia,Grégoire Laurent,Morissette Marc,Calon Fréderic,Hadj Tahar Abdallah,Dridi Mehdi,Belanger Nancy,Meltzer Leonard T.,Bédard Paul J.,Di Paolo Thérèse

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Developmental Biology,Clinical Neurology,Ageing,General Neuroscience

Reference59 articles.

1. NMDA-induced potentiation of mGluR5 is mediated by activation of protein phosphatase 2B/calcineurin;Alagarsamy;Neuropharmacology,2005

2. Characterization of MK-801-induced behavior as a putative rat model of psychosis;Andine;J. Pharmacol. Exp. Ther.,1999

3. Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals;Bamford;Neuron,2004

4. Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice;Battaglia;J. Neurosci.,2004

5. Chronic treatment with small doses of cabergoline prevents dopa-induced dyskinesias in parkinsonian monkeys;Belanger;Mov. Disord.,2003

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Type-B monoamine oxidase inhibitors in neurological diseases;Neural Regeneration Research;2024-01

2. Targeting Striatal Glutamate and Phosphodiesterases to Control L-DOPA-Induced Dyskinesia;Cells;2023-11-30

3. Metabotropic glutamate receptors in Parkinson's disease;International Review of Neurobiology;2023

4. Non-dopaminergic approaches to the treatment of motor complications in Parkinson's disease;Neuropharmacology;2022-06

5. Glutamatergic Treatments for Parkinson’s Disease;Glutamate and Neuropsychiatric Disorders;2022